Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 39KS9 | — |
patient was maladministered with an expired dose of PEDIARIX on an eight month old patient.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 8-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 39KS9, expiry date 07-SEP-2025) for prophylaxis. On 15-SEP-2025, the patient received Pediarix. On 15-SEP-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: patient was maladministered with an expired dose of PEDIARIX on an eight month old patient.). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-SEP-2025 The patient was maladministered with an expired dose of Pediarix. Nurse needed advice on this matter. No further information was obtained.